The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy.

Tam, Constantine S; O'Brien, Susan; Lerner, Susan; Khouri, I; Ferrajoli, A; Faderl, S; Browning, M; Tsimberidou, Apostolia M; Kantarjian, Hagop; Wierda, William G

Tam, Constantine S; O'Brien, Susan; Lerner, Susan; Khouri, I; Ferrajoli, A; Faderl, S; Browning, M; Tsimberidou, Apostolia M; Kantarjian, Hagop; Wierda, William G.

Affiliation

Tam CS; Department of Leukemia and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

Leuk Lymphoma ; 48(10): 1931-9, 2007 Oct.

Article in En | MEDLINE | ID: mdl-17917961

Subject(s)

Antibodies, Monoclonal/pharmacology; Antibodies, Neoplasm/pharmacology; Drug Resistance, Neoplasm; Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy; Leukemia, Lymphocytic, Chronic, B-Cell/pathology; Lymphatic Diseases/drug therapy; Vidarabine/analogs & derivatives; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents/pharmacology; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell/therapy; Lymphatic Diseases/pathology; Lymphatic Diseases/therapy; Male; Middle Aged; Models, Biological; Rituximab; Stem Cell Transplantation/methods; Transplantation, Homologous; Treatment Outcome; Vidarabine/pharmacology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vidarabine / Leukemia, Lymphocytic, Chronic, B-Cell / Drug Resistance, Neoplasm / Lymphatic Diseases / Antibodies, Monoclonal / Antibodies, Neoplasm Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2007 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links